We have developed our own in-house Immunomonitoring capability consistent with our mission to become a world leader in immunotherapy. Immunomonitoring is the use of analytical tools and reagents to probe the events that occur in an immune response. This capability is key to assisting us in our understanding of the intricacies of the immune system. From such an understanding, we are able to improve our current products, develop new products and increase the types of indications we can treat. The immune system is the only technology known with the capability of curing cancer and other diseases. The immune system can “sterilize” the body of unwanted agents, including cancer cells and viruses. Understanding and learning to control the immune system is our power.



Treatment strategy designed to use the power of the human immune system to kill tumors and prevent their recurrence.
No requirement for a matched donor or chemotherapy/radiation conditioning prior to treatment.
Innovative technology – proven and non-toxic.
read more

Healthcare professionals

Therapeutic anti-tumor vaccine developed from core break-through technology called the "Mirror Effect™“ which opens a pathway to treating patients with metastatic cancer that have failed all available therapy options.
Elicits a GVT-like mechanism without the GVHD toxicity.
read more


Privately-held Israeli biopharmaceutical company spin out from Hadassah-Hebrew University Medical Center with headquarters in Jerusalem.

Over 200 individual private shareholders and grant support from the Israel Office of the Chief Scientist.
read more